Invasive Pulmonary Fungal Infections in Cystic Fibrosis

Carsten Schwarz1, Claudia Brandt2, Paul Whitaker3

  • 1Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. carsten.schwarz@charite.de.

Mycopathologia
|September 3, 2017
PubMed

Insights

Pulmonary mycoses, excluding allergic bronchopulmonary aspergillosis (ABPA), are serious in cystic fibrosis (CF). Early diagnosis and targeted antifungal treatment are vital for better outcomes in CF patients.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Mycology

Background:

  • Invasive pulmonary mycosis is a frequent and severe complication in cystic fibrosis (CF) lung disease, often following allergic bronchopulmonary aspergillosis (ABPA).
  • Caregivers express uncertainty regarding the diagnosis and treatment of fungal lung infections in CF patients.
  • Non-ABPA pulmonary mycoses represent a significant challenge in CF management.

Purpose of the Study:

  • To present a multicenter experience on the diagnosis, manifestation, and treatment of non-ABPA pulmonary mycoses in patients with CF.
  • To highlight the role of specific fungal species and treatment strategies.
  • To identify needs for improved diagnostic and therapeutic approaches.

Main Methods:

  • A case series approach was employed, collecting data from CF centers in Germany, the UK, and Spain.
  • Non-ABPA was defined by a total serum IgE level below 500 kU/L.
  • Data on diagnostic methods, clinical manifestations, and treatment regimens were analyzed.

Main Results:

  • Scedosporium and Lomentospora species demonstrated higher virulence in CF patients.
  • Successful treatment of these infections was achieved with triple antifungal drug regimens in several instances.
  • Antibiotic treatment failure was a primary indicator for initiating antifungal therapy.

Conclusions:

  • Rare fungi, including yeasts, can be pathogenic in CF patients.
  • Identifying biomarkers and risk factors beyond antibiotic treatment failure is crucial for early and effective management of pulmonary mycoses in CF.
  • Further treatment efficacy studies are necessary for various causative agents.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
932
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
573
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
982
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
600
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
1.6K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K